Kesimpta 00078-1007-98
Generic: Ofatumumab
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 26, 2009
- Listing Expires
- December 31, 2027
- Application
- BLA125326
Need to source Kesimpta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ofatumumab | 20 mg/.4mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Selected Package
00078-1007-98Selected1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS
Other packages for this product(1)
1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS